COVID-19 and Cardiovascular Comorbidities

Experimental and Clinical Endocrinology & Diabetes, vol. 130, pp. 178–189

Abstract

The emergence of a new coronavirus - severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) - has resulted in a global pandemic. The associated coronavirus disease 2019 (COVID-19) has resulted in a high number of death worldwide. Observational studies and case reports have provided insights that older age and the presence of chronic diseases is frequently associated with a higher COVID-19 severity. These individuals also seem to have a higher risk of mortality due to COVID-19. In this review we provide insights into the impact chronic diseases associated with the cardiovascular system, such as obesity, diabetes mellitus, hypertension and cardiovascular disease might have on SARS-CoV-2 infection and COVID-19. Additionally we review recommendations and guidance's of international scientific associations and discuss which key learnings might be of importance for the future.

Authors 5

1. Dirk Müller‐Wieland Aachen Clinic for Cardiology (Internal Medicine I)

   Universitätsklinikum Aachen

   Affiliation as printed

   Clinic for Cardiology, Angiology and Internal Care Medicine (Medical Clinic I) Universitatsklinikum Aachen, Aachen

2. Nikolaus Marx Aachen Clinic for Cardiology (Internal Medicine I)

   Universitätsklinikum Aachen

   Affiliation as printed

   Clinic for Cardiology, Angiology and Internal Care Medicine (Medical Clinic I) Universitatsklinikum Aachen, Aachen

3. Michael Dreher Aachen Clinic for Pneumology and Internal Intensive Care Medicine (Medical Clinic V

   Universitätsklinikum Aachen

   Affiliation as printed

   Clinic for Pneumology and Internal Intensive Care Medicine (Medical Clinic V, Uniklinik RWTH Aachen, Aachen

4. Katharina Fritzen
   Affiliation as printed

   Sciarc GmbH, Baierbrunn

5. Oliver Schnell
   Affiliation as printed

   Forschergruppe Diabetes e.V., Munich Neuherberg

   Sciarc GmbH, Baierbrunn